Dr. Mitchell S. Herold, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Florida College of Medicine (2019)
- Years since graduation
- 7
- In the NPI registry since
- 2019
- Medicare patients seen, 2024
- 174
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2019Medical school: University of Florida College of Medicine
- 2019Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
FL license 94861 -
MOHS-Micrographic Surgery Physician
FL license 94861
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Texas Dermatology and Laser Specialists PLLC (20 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 174
- Services billed
- 947
- Patients’ average age
- 74
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Triamcinolone Acetonide Other prescribers in San Antonio, TX | 22 |
| Doxycycline Hyclate Other prescribers in San Antonio, TX | 17 |
| Ketoconazole Other prescribers in San Antonio, TX | 15 |
| Doxycycline Monohydrate Other prescribers in San Antonio, TX | 13 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 66 payments worth $1,674 in total to this clinician.
| Regeneron Healthcare Solutions, Inc. | $482 |
|---|---|
| AbbVie Inc. | $271 |
| Genzyme Corporation | $237 |
| UCB, Inc. | $173 |
| Galderma Laboratories, L.P. | $163 |
| Krystal Biotech Inc | $125 |
| Incyte Corporation | $88.50 |
| Janssen Biotech, Inc. | $36.03 |
| Food and Beverage | $1,594 |
|---|---|
| Education | $80.86 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Jun 23, 2025 | Education DUPIXENT · IMMUNOLOGY AND INFLAMMATION · in-kind | $80.86 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.